You have no items in your shopping cart.
IL-2 Antibody
Description
Images & Validation
−| Tested Applications | ELISA, WB |
|---|---|
| Dilution range | ELISA: 1:10,000, WB: 1:1,000 |
| Reactivity | Human |
| Application Notes |
Key Properties
−| Antibody Type | Primary Antibody |
|---|---|
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Immunogen | IL-2 antibody was prepared from whole rabbit serum produced by repeated immunizations with full length recombinant human IL-2 protein. |
| Purity | This product is an IgG fraction antibody purified from monospecific antiserum by a multi-step process which includes delipidation, salt fractionation and ion exchange chromatography followed by extensive dialysis against the buffer stated above. This purified antibody has been heated to 56°C for 30 minutes. In ELISA and other immunoreactive assays, this antibody will recognize both native and recombinant human IL-2 in cell supernatants and certain body fluids. A control of similarly diluted normal rabbit IgG is recommended. |
| Conjugation | Unconjugated |
Storage & Handling
−| Storage | Store Anti-IL-2 antibody at 4° C prior to restoration. For extended storage aliquot contents and freeze at -20° C or below. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use. |
|---|---|
| Form/Appearance | Lyophilized |
| Buffer/Preservatives | Preservative: None. Stabilizer: None; Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2 |
| Concentration | 1.0 mg/mL |
| Disclaimer | For research use only |
Alternative Names
−Similar Products
−PD-L1 Antibody / B7-H1 / CD274 [orb606675]
ELISA, FACS, IF, IHC-P, WB
Human, Mouse
Mouse
Monoclonal
Unconjugated
100 μg, 20 μgPD-L1 Antibody / B7-H1 / CD274 [orb2641418]
ELISA, FACS, IF, IHC-P, WB
Human, Mouse
Mouse
Monoclonal
Unconjugated
100 μgZEB1/NIL2A Rabbit Polyclonal Antibody [orb6954]
FC, IF, IHC-Fr, IHC-P, WB
Bovine, Canine, Gallus, Porcine, Rabbit
Human, Mouse, Rat
Rabbit
Polyclonal
Unconjugated
50 μl, 100 μl, 200 μlAnti-IL-2R alpha (CD25) [Basiliximab] [orb348865]
Blocking, FC, IF, IHC, WB
Human, Primate
Human
Monoclonal
Unconjugated
0.2 mgAnti-IL-2R alpha (CD25) [Basiliximab] [orb348908]
Blocking, FC, IF, IHC, WB
Human, Primate
Human
Monoclonal
Unconjugated
0.2 mg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Biorbyt's anti-Human IL-2 antibody shows detection of a band ~15 kDa in size corresponding to recombinant human IL-2. The identity of the faint higher molecular weight band may represent a homodimer. Molecular weight markers are also shown (left). After transfer, the membrane was blocked overnight with 3% BSA in TBS followed by reaction with primary antibody at a 1:1000 dilution. Detection occurred using peroxidase conjugated anti-Rabbit IgG (p/n orb347654) secondary antibody diluted 1:40000 in blocking buffer (p/n orb348637) for 30 min at RT followed by reaction with FemtoMax™ chemiluminescent substrate.
Quick Database Links
UniProt Details
−NCBI Reference Sequences
−| Protein | NP_000577.2 |
|---|
Documents Download
Request a Document
Protocol Information
IL-2 Antibody (orb345144)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review



























![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348865_1.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348865_2.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348865_3.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348865_4.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348865_5.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348865_6.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348908_1.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348908_2.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348908_3.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348908_4.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348908_5.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348908_6.png)